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Introduction: Veillonella is a nonfermentative, strictly anaerobic, Gram-negative coccus that forms part of the
human gastrointestinal tract, mouth and vaginal flora. Like other anaerobic infection, Veillonella species usually are
involved in polymicrobial processes, which make it difficult to determine their pathogenic role. Isolation of a
clinically significant Veillonella species is rare and V. parvula is the most common one reported to cause infection in
humans. The most frequently reported infection caused by V. parvula is osteomyelitis, almost always in association
with bacteremia.
Case presentation: Here, we describe a rare case of nonvertebral osteomyelitis and septicemia caused by
Veillonella species in a 49-year-old Saudi man with diabetes. Initial treatment with ciprofloxacin was associated with
treatment failure and poor response. Identification of the organism was essential for the selection of appropriate
treatment. There have been only seven previous reports of Veillonella vertebral osteomyelitis and one report of
V. parvula foot osteomyelitis with sepsis in the literature. This is the second case of Veillonella nonvertebral osteomyelitis
associated with septicemia reported to date.
Conclusions: Veillonella species should be considered a true pathogen in diabetic patients with osteomyelitis and
those with underlying immune suppression, particularly if the organism is isolated from blood. The isolation of those
obligate anaerobes from blood may signal the presence of severe underlying disease and the probable need for timely
surgical intervention.
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Veillonella is a nonfermentative, small, nonmotile, strictly
anaerobic, Gram-negative cocci that form part of the nor-
mal flora of the oral, respiratory, intestinal, and female
genital tracts [1]. They are usually recovered as part of a
polymicrobial infection and they are often regarded as a
contaminant. However, they have been isolated in pure
culture from various sterile body sites such as sinuses,
lungs, liver, central nervous system, heart, and bone. Veil-
lonella parvula is the most common clinically significant
species and is infrequently grow from blood cultures. We
report here a case of Veillonella species bacteremia associ-
ated with osteomyelitis in which pure Veillonella species* Correspondence: ofawzia@ksu.edu.sa
King Khalid University Hospital, King Saud University, PO: 2925, Riyadh 11461,
Saudi Arabia
© 2014 Al-Otaibi and Al-Mohizea; licensee Bio
the Creative Commons Attribution License (ht
bution, and reproduction in any medium, pro
main Dedication waiver (http://creativecomm
unless otherwise stated.was isolated from blood culture. This is the second
reported case of Veillonella nonvertebral osteomyelitis,
which illustrates the pathogenic potential of this organism
in causing invasive infection in diabetic patients.
Case presentation
A 49-year-old Saudi man, a known case of insulin-
dependent diabetes mellitus (IDDM), hypertension and
ischemic heart disease, presented to the emergency de-
partment with a three-day history of fever, chills and
ankle pain after trauma to his left foot. He reported a
nonhealing ulcer on his left heel following a hot sur-
face injury 20 days prior to his presentation. On exam-
ination, our patient looked ill and septic, with minimal
ambulation. His temperature was 38.9°C and his blood
pressure and pulse were 140/90mmHg and 108 beats/
minutes respectively. A lower limb examination revealedMed Central Ltd. This is an Open Access article distributed under the terms of
tp://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distri-
vided the original work is properly credited. The Creative Commons Public Do-
ons.org/publicdomain/zero/1.0/) applies to the data made available in this article,
Al-Otaibi and Al-Mohizea Journal of Medical Case Reports 2014, 8:365 Page 2 of 6
http://www.jmedicalcasereports.com/content/8/1/365bilateral decrease of sensation and a foot ulcer on his left
heel. Careful examination of his left foot showed a 7×5cm
deep ulcer on the lateral side that looked badly infected
with change of skin color and profuse pus discharge.
Our patient was seen by the orthopedic surgeon and an
urgent extensive wound debridement involving the boneFigure 1 Left foot magnetic resonance imaging. (A) A left foot MRI sca
separated into two segments ((A) and (P)) with evidence of anterior segmewas undertaken. Blood, pus and bone tissue specimens
were collected and sent to the microbiology laboratory for
culture and sensitivity testing. A laboratory examination
showed a white cell count (WBC) of 29×109g/L with 90%
neutrophils, hemoglobin of 6.9g/L, and an erythrocyte
sedimentation rate (ESR) of 97mm/h. His serum creatininen revealed a fracture in the calcaneus. (B) The calcaneus bone is
nt osteomyelitis and a deep, infected ulcer (arrows).
Figure 2 Blood agar plate after 48 hours of anaerobic
incubation showing tiny colonies of Veillonella organism.
Figure 3 Gram stain from anaerobic culture plate showing
small Gram-negative cocci.
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test results were within normal limits except for serum al-
kaline phosphatase (ALP), which was raised (785IU/L). A
left foot X-ray revealed soft tissue swelling, gas formation
and fracture of the calcaneus bone. A left foot magnetic
resonance imaging (MRI) scan revealed a calcaneus fracture
with high suspicion of calcaneus anterior fragment osteo-
myelitis (Figure 1). An MRI scan of his right foot revealed
mild neuropathic arthropathy (Charcot joint) with no evi-
dence of osteomyelitis. Our patient was started empirically
on intravenous ciprofloxacin 400mg twice daily, and intra-
venous clindamycin 600mg eight hourly. During the first
three days after starting treatment, our patient showed no
clinical improvement and he continued to run a low-grade
fever. A pus culture grew Escherichia coli sensitive to
ciprofloxacin, imipenem, meropenem, gentamicin and
Enterococcus avium sensitive to ampicillin. A bone and
tissue biopsy grew Morganella morganii sensitive to
gentamicin, imipenem and resistant to ciprofloxacin,
ampicillin, amoxicillin-clavulanic acid, piperacillin/tazo-
bactam and cotrimoxazole. No growth occurred on the
anaerobic plates despite prolonged incubation. Based on
culture results, the initial antibiotics were suspended
and our patient was started on imipenem 500mg intra-
venously (IV) six hourly, vancomycin 1g IV 12 hourly,
and colistin 2 million units IV eight hourly. The blood
culture obtained before treatment initiation, which was
inoculated in an anaerobic bottle (Bactec Lytic/10, An-
aerobic/F, Beckton Dickinson, Franklin Lakes, NJ, USA)
and processed by an automated blood culture system
(Bactec FX, Beckton Dickinson), grew very scanty Gram-
negative cocci within 18 hours shown on Gram stain. The
blood then was subcultured on Trypticase soy agar with
sheep blood (BBL Microbiology Systems, Cockeysville,
MD, USA) and incubated at 35°C in 5% CO2, in an anaer-
obic GasPak™ jar (BBL Microbiology Systems). After 48
hours of anaerobic incubation, the blood agar grew slow-
growing tiny colonies (Figure 2) that showed Gram-
negative cocci on Gram stain (Figure 3). The organism
was identified by the Vitek 2 automated system (bio-
Mérieux, Marcy-l'Étoile, France), as Veillonella species
with a 99% probability rate. It was sensitive to imipenem
(1.5μg/ml), clindamycin (0.047μg/ml), ceftriaxone (8μg/ml)
and colistin, and resistant to penicillin (>32μg/ml), vanco-
mycin, erythromycin and metronidazole. Further identifi-
cation to species level and genotyping was unable to be
performed, as the subcultured isolates failed to grow
and the significant time delay before attempting to rei-
solate the organisms from the blood culture bottle ren-
dered them nonviable. Over the subsequent five days,
our patient’s condition worsened with a high temperature
(38.9°C), rigors, a high WBC and ESR count. The wound
was reevaluated by the surgical team and a decision of
above-knee amputation was taken. Colistin and vancomycinwere discontinued and imipenem was continued for four
weeks. On follow-up, our patient showed gradual improve-
ment of his condition and was discharged.
Discussion
Veillonella species are rare causes of serious infections
such as meningitis [2], endocarditis [3], obstructive pneu-
monitis [4], prosthetic joint infection [5], and bacteremia
[6]. Bacteremia has been reported almost always in associ-
ation with an underlying infection such as osteomyelitis.
There have been seven previous reports of vertebral osteo-
myelitis [7-13] and one report of foot cellulitis and osteo-
myelitis in a middle-aged woman associated with sepsis
caused by V. parvula [14] (Table 1). Our report is consid-
ered to be the second report of Veillonella nonvertebral
osteomyelitis associated with bacteremia. Borchardt [14]
reported the first case of nonvertebral osteomyelitis in
which a 54-year-old Indian diabetic woman developed
foot cellulitis and toe osteomyelitis after attempting to
Table 1 Previously reported cases of osteomyelitis caused by Veillonella
Number of patients
(reference)
Age (year)/sex Culture result Underlying disease/risk factors Type of bone/soft tissue Antibiotic therapy
Blood Bone/disc
1. (This study) 49/M Veillonella
sp.
NR Diabetes mellitus and diabetic foot Foot bone (Calcenous) Imipenem
2. Marriott [7] 55/M V. parvula V. parvula Colonoscopy Lumbar spine discitis Ceftriaxone
3. Singh [8] 61/F V. parvula V. parvula Sjogren’s syndrome, xerostomia- Thora columbar spine Ceftriaxone
4. Bongaerts [9] 74/M NR V. parvula None Spine Penicillin
5. Hidalgo [10] 70/M NR V. parvula None Spine US
6. Isner-Horobeti [11] 27/M NR Veillonella sp. None Lumbar spondylodiscitis Amoxicillin
7. Kishen [12] 76/F Veillonella
sp.
Veillonella sp. None Lumbar spondylodiscitis and
paraspinal space abscesses
Spinal surgery + Cefotaxime/
metronidazole
8. Barnhart [13] 31/M NR Veillonella sp. Cervical vertebral fracture/Post cervical
spine fusion
Cervical spine and retropharyngeal
abscess
Penicillin G + abscess drainage
9. Borchardt [14] 54/F V. parvula V. parvula Diabetes mellitus and foot shaving injury Phalanx and metatarsal bone and
cellulitis
Excision of infected bone + penicillin
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entation. The patient recovered completely after exci-
sion of the phalanx and metatarsal bones along with
four weeks of intravenous penicillin treatment. V par-
vula was isolated from the excised tissue and the blood
culture. In five of the previously reported clinical infec-
tions, the patients were previously healthy and the por-
tal of entry was not identified. Isner-Horobeti [11]
reported on a 27-year-old man with unknown risk fac-
tors for infection, who presented with an L4 to L5 spon-
dylodiscitis. The patient was cured after a prolonged
course (11 weeks) of intravenous followed by oral peni-
cillin. In another report by Bongaerts [9] V. parvula was
isolated from the spine (T12 to L1) of a previously healthy
74-year-old man who was treated with six weeks of intra-
venous penicillin. Similar cases were reported by Hidalgo
[10] and Kishen et al. [12] of Veillonella spondylodiscitis
in older patients without any risk factors. The outcome of
the patients was favorable after antibiotic treatment alone
or combined with surgical management. On the other
hand, colonoscopy was considered by Marriott [7] as a
possible source of entry of V. parvula causing bacteremia
and lumbar discitis in a 55-year-old man who had under-
gone small intestinal and rectal biopsies eight weeks prior
to presentation. In another report by Barnhart [13], post-
operative Veillonella osteomyelitis of the cervical spine
was reported from a 31-year-old man who had suffered a
cervical fracture at the level of the fourth and fifth cervical
vertebrae two months before presentation. The possible
source of entry of the organism was thought to be the
esophageal perforation that had occurred during surgery.
Veillonella was isolated repeatedly from a retropharyngeal
soft tissue abscess, which was drained followed by paren-
teral penicillin administration for six weeks. The best
method for identification of Veillonella strains at the spe-
cies level requires direct sequencing of the 16S rRNA gene
[15]. Conventional phenotypic and biochemical testing
does not provide adequate discrimination between species.
The pathogenic role of these anaerobes has not been
established. However, previously published reports dem-
onstrated their role as a true pathogen associated with
fatal overwhelming septicemia [6]. In our case, in which
Veillonella species was isolated in pure culture from blood
in a patient with signs of severe diabetic wound infection
illustrates the pathogenic role of this microorganism. The
strictly anaerobic organism failed to grow from the wound
probably due to improper sample collection and transport
supportive of anaerobic culture. In addition, the presence
of other rapidly growing aerobic organisms as part of the
polymicrobial infection might interfere with their recovery
from wound infection. Veillonella is usually vancomycin,
tetracycline, aminoglycosides, and ciprofloxacin resistant
and infection typically responds well to therapy with peni-
cillin. Other antimicrobial agents to which the organism isusually susceptible in vitro include cephalosporins, clinda-
mycin, metronidazole, and chloramphenicol. There are no
clear treatment recommendations in the literature due to
the scarce number of reports on Veillonella as a pathogen
associated with invasive infection. However, the previous
few reports showed good response to antibiotics such as
penicillin, cephalosporins, chloramphenicol, clindamycin
and metronidazole [16-20]. Metronidazole was suggested
by Warner et al. [16] as an effective drug for the manage-
ment of serious infections like bacteremia, brain abscess,
and meningitis. The isolate from our case showed unusual
high minimum inhibitory concentration (MIC) to penicillin
(>32μg/ml). However, in a recent study Veillonella species
isolated from the oral cavities of humans demonstrated
a high level of resistance to penicillin G (MIC, 2μg/ml)
[21] and reduced susceptibility to ampicillin or amoxi-
cillin. Reports on the management of infections caused
by Veillonella isolates demonstrating high MIC to penicil-
lin is lacking due to limited published studies on the sus-
ceptibility of Veillonella species to different antimicrobial
agents, particularly penicillin, and their clinical effectiveness.
Conclusion
Veillonella species should be considered a true pathogen
in diabetic patients with osteomyelitis and those with
underlying immune suppression, particularly if the or-
ganism is isolated from blood. The isolation of those ob-
ligate anaerobes from blood may signal the presence of
severe underlying disease and the probable need for
timely surgical intervention.
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